NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

OK, yes it was Roach (obviously, as they own Herceptin)

But now you say IMGN went downhill because their pipeline failed. Before you blamed it on shorts?

One can debate what clinical failure led to the long winter. For me, the Marrianne failure of T-DM1 in first line was the decision to leave. That was a P3, the rest of the pipeline had a ways to go.